Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has...
Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement
Enlaza and Vertex Pharmaceuticals Enter Multi-Target Drug Discovery Collaboration
Cooley and Wilson Sonsini Goodrich & Rosati have advised Enlaza Therapeutics, and Covington has advised Vertex Pharmaceuticals. Enlaza Therapeutics has entered into a multi-target drug discovery...
Janux Therapeutics’ $350 Million Common Stock Offering
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Drata’s $200 Million Series C Funding Round
Cooley advised Drata on the deal. Drata, a continuous security and compliance automation platform, announced its $200 million Series C funding round. The latest round of funding,...
Drata’s $100 Million Series B Financing Round
Cooley LLP advised Drata on the deal. Drata, a next-generation security and compliance automation company, announced its $100 million Series B financing round, which brings the company’s...